Literature DB >> 12605698

The antibody response to HBs antigen is regulated by coordinated Th1 and Th2 cytokine production in healthy neonates.

A Jafarzadeh1, F Shokri.   

Abstract

A proportion of healthy neonates fail to produce protective levels of anti-HBs antibody following vaccination with recombinant hepatitis B vaccine. This study was undertaken to investigate contribution of Th1 and Th2 responses to anti-HBs antibody production and to explore the mechanism(s) of unresponsiveness to HBsAg in human neonates. Peripheral blood manonuclear cells (PBMCs) were isolated form 28 nonresponder (anti-HBs antibody <10 IU/l) and 25 responder neonates. The cells were stimulated in vitro with recombinant HBsAg and PHA mitogen and concentrations of IL-4, IL-10 and IFN-gamma were quantified in culture supernatants by sandwich ELISA. Our results demonstrated significantly increased production of all cytokines, including IL-4 (P < 0.001), IL-10 (P < 0.002) and IFN-gamma (P < 0.01) in responder compared to nonresponder vaccinees. No significant differences, however, were observed between the two groups of neonates in the levels of cytokines induced by PHA or secreted in absence of antigen and mitogen. Our findings suggest that unresponsiveness to recombinant HBsAg in healthy neonates is linked to inadequate secretion of both Th1 and Th2 cytokines.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12605698      PMCID: PMC1808652          DOI: 10.1046/j.1365-2249.2003.02093.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  31 in total

1.  High seroprotection rate induced by low doses of a recombinant hepatitis B vaccine in healthy Iranian neonates.

Authors:  F Shokri; A Jafarzadeh
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

2.  Diminished Th1 and Th2 cytokine production in healthy adult nonresponders to recombinant hepatitis B vaccine.

Authors:  G A Kardar; M Jeddi-Tehrani; F Shokri
Journal:  Scand J Immunol       Date:  2002-03       Impact factor: 3.487

3.  Selective killing of hepatitis B envelope antigen-specific B cells by class I-restricted, exogenous antigen-specific T lymphocytes.

Authors:  V Barnaba; A Franco; A Alberti; R Benvenuto; F Balsano
Journal:  Nature       Date:  1990-05-17       Impact factor: 49.962

4.  Comparative analysis of HLA restriction and cytokine production in hepatitis B surface antigen-specific T cells from low- and high-antibody responders in vaccinated humans.

Authors:  M Wataya; T Sano; N Kamikawaji; T Tana; K Yamamoto; T Sasazuki
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

5.  Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

Authors:  D R Milich; J E Jones; J L Hughes; J Price; A K Raney; A McLachlan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

6.  Subtype specificity of anti-HBs antibodies produced by human B-cell lines isolated from normal individuals vaccinated with recombinant hepatitis B vaccine.

Authors:  Mohammad Ali Shokrgozar; Fazel Shokri
Journal:  Vaccine       Date:  2002-05-22       Impact factor: 3.641

7.  There is no correlation between function and lymphokine production of HBs-antigen-specific human CD4(+)-cloned T cells.

Authors:  H Tsutsui; Y Mizoguchi; S Morisawa
Journal:  Scand J Immunol       Date:  1991-10       Impact factor: 3.487

8.  Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines.

Authors:  J N Zuckerman; A J Zuckerman; I Symington; W Du; A Williams; B Dickson; M D Young
Journal:  Hepatology       Date:  2001-10       Impact factor: 17.425

Review 9.  Hepatitis B virus immunopathogenesis.

Authors:  F V Chisari; C Ferrari
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

10.  Deficient T-cell responses in non-responders to hepatitis B vaccination: absence of TH1 cytokine production.

Authors:  J Vingerhoets; G Vanham; L Kestens; G Penne; G Leroux-Roels; P Gigase
Journal:  Immunol Lett       Date:  1994-02       Impact factor: 3.685

View more
  9 in total

1.  Differential reactivity of mouse monoclonal anti-HBs antibodies with recombinant mutant HBs antigens.

Authors:  Azam Roohi; Yaghoub Yazdani; Jalal Khoshnoodi; Seyed Mohammad Jazayeri; William F Carman; Mahmood Chamankhah; Manley Rashedan; Fazel Shokri
Journal:  World J Gastroenterol       Date:  2006-09-07       Impact factor: 5.742

2.  Hepatitis B-specific T helper cell responses in uninfected infants born to HBsAg+/HBeAg- mothers.

Authors:  Lemonica Koumbi; Antonio Bertoletti; Vassiliki Anastasiadou; Maria Machaira; Winnie Goh; Nikolaos G Papadopoulos; Dimitris A Kafetzis; Vassiliki Papaevangelou
Journal:  Cell Mol Immunol       Date:  2010-07-26       Impact factor: 11.530

Review 3.  General Anesthetics on Immune System Cytokines: A Narrative Review Article.

Authors:  Abdollah Jafarzadeh; Maryam Hadavi; Gholamhossein Hassanshahi; Mohsen Rezaeian; Reza Vazirinejad
Journal:  Anesth Pain Med       Date:  2020-07-05

4.  The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy.

Authors:  Masoomeh Bagheri-Jamebozorgi; Jila Keshavarz; Maryam Nemati; Saeed Mohammadi-Hossainabad; Mohammad-Taghi Rezayati; Mohsen Nejad-Ghaderi; Ahmad Jamalizadeh; Fazel Shokri; Abdollah Jafarzadeh
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

5.  Nonimmunity against hepatitis B virus infection in patients newly diagnosed with inflammatory bowel disease.

Authors:  Seong Jae Yeo; Hyun Seok Lee; Byung Ik Jang; Eun Soo Kim; Seong Woo Jeon; Sung Kook Kim; Kyeong Ok Kim; Yoo Jin Lee; Hyun Jik Lee; Kyung Sik Park; Yun Jin Jung; Eun Young Kim; Chang Heon Yang
Journal:  Intest Res       Date:  2018-07-27

6.  Immunoadjuvant Activity of Fucoidans from the Brown Alga Fucus evanescens.

Authors:  Tatyana A Kuznetsova; Tatyana P Smolina; Ilona D Makarenkova; Lydmila A Ivanushko; Elena V Persiyanova; Svetlana P Ermakova; Artem S Silchenko; Tatyana S Zaporozhets; Natalya N Besednova; Lydmila N Fedyanina; Sergey Р Kryzhanovsky
Journal:  Mar Drugs       Date:  2020-03-11       Impact factor: 5.118

Review 7.  Immune response to vaccines in children with celiac disease.

Authors:  Caterina Anania; Francesca Olivero; Alessandra Spagnolo; Claudio Chiesa; Lucia Pacifico
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

Review 8.  Contribution of STAT3 to the pathogenesis of COVID-19.

Authors:  Abdollah Jafarzadeh; Maryam Nemati; Sara Jafarzadeh
Journal:  Microb Pathog       Date:  2021-03-07       Impact factor: 3.848

9.  Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24highCD38high Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders.

Authors:  Nina Körber; Laureen Pohl; Birgit Weinberger; Beatrix Grubeck-Loebenstein; Andrea Wawer; Percy A Knolle; Hedwig Roggendorf; Ulrike Protzer; Tanja Bauer
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.